Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - CHANGE IN WORKING CAPITAL
Change in Working Capital ITCI - Intra-Cellular Therapies, Inc.
-29.6 M
LAST VALUE
-115.77%
2 YEAR CAGR
-19.95%
5 YEAR CAGR
-24.09%
10 YEAR CAGR